相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An increase in cell number at completion of therapy may develop as an indicator of early relapse
Katharina Pachmann et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer
O. Camara et al.
ANNALS OF ONCOLOGY (2007)
Quantification of circulating tumour cells for the monitoring of adjuvant therapy in breast cancer:: An increase in cell number at completion of therapy is a predictor of early relapse
Kurt Lobodasch et al.
BREAST (2007)
The measurement and therapeutic implications of circulating tumour cells in breast cancer
JB Smerage et al.
BRITISH JOURNAL OF CANCER (2006)
Comparison of gene expression profiles in core biopsies and corresponding surgical breast cancer samples
Rosanna Zanetti-Daellenbach et al.
BREAST CANCER RESEARCH (2006)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
A pooled analysis of bone marrow micrometastasis in breast cancer
S Braun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Longtime recirculating tumor cells in breast cancer patients
K Pachmann
CLINICAL CANCER RESEARCH (2005)
Detection of micrometastatic disease in bone marrow: Is it ready for prime time?
W Janni et al.
ONCOLOGIST (2005)
Drug resistance in cancer: Principles of emergence and prevention
NL Komarova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Circulating tumor cells in breast cancer:: Correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity
V Müller et al.
CLINICAL CANCER RESEARCH (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence
W Janni et al.
CANCER (2005)
30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study
G Bonadonna et al.
BRITISH MEDICAL JOURNAL (2005)
Taxanes in adjuvant breast cancer setting: Which standard in Europe?
M Campone et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2005)
Standardized quantification of circulating peripheral tumor cells from lung and breast cancer
K Pachmann et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2005)
Quantification of the response of circulating epithelial cells to neodadjuvant treatment for breast cancer: a new tool for therapy monitoring
K Pachmann et al.
BREAST CANCER RESEARCH (2005)
Single agent versus combination chemotherapy for metastatic breast cancer - art. no. CD003372.pub2
S Carrick et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2005)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Circulating tumor cells in patients with breast cancer dormancy
SD Meng et al.
CLINICAL CANCER RESEARCH (2004)
Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour
R Demicheli et al.
BREAST CANCER RESEARCH (2004)
Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases
GN Naumov et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Detection and quantification of small numbers of circulating tumour cells in peripheral blood using laser scanning cytometer (LSC®)
K Pachmann et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2001)
分享论文
